Type 2 Diabetes With Obesity# Recommendation : CagriSema Reason : REDEFINE 2 showed 13.7% weight loss with 73.5% of T2D patients achieving HbA1c of 6.5% or less, exceeding semaglutide's glycemic and weight results in T2D trials
Similarly, recent long-term studies of liraglutide and semaglutide, focusing on cardiovascular outcomes in individuals with type 2 diabetes, reveal a similar incidence of pancreatitis between groups treated with the GLP-1R agonists and placebo [31, 41]
plantarum probiotic separately
Page Six has all the details on the 44-year-old comedian and mom-of-one's dramatic weight-loss journey
(In general, you should not take extra tablets or double your next dose to make up for the missed one, as doing so may increase the risk of side effects.) Whenever possible, avoid making changes to your dosing schedule unless your healthcare provider explicitly recommends those precise changes